News

PMCPA News

Press releases appear below, filter by date.

New PMCPA Director appointed

New PMCPA Director appointed

Press release: 23 February 2022
Vacancies for independent members of the Code of Practice Appeal Board

Vacancies for independent members of the Code of Practice Appeal Board

Press release: 20 January 2022
The PMCPA is recruiting ​

The PMCPA is recruiting ​

Press release: 13 January 2022
Novartis, Camurus, Pfizer and Boehringer Ingelheim have been named in advertisements for breaches of the ABPI Code

Novartis, Camurus, Pfizer and Boehringer Ingelheim have been named in advertisements for breaches of the ABPI Code

Press release: 21 October 2021
LEO Pharma, Norgine, Daiichi-Sankyo, Novartis, Sanofi, Consilient, and Pharmasure have been named in advertisements for breaches of the ABPI Code

LEO Pharma, Norgine, Daiichi-Sankyo, Novartis, Sanofi, Consilient, and Pharmasure have been named in advertisements for breaches of the ABPI Code

Press release: 02 August 2021
GUIDELINES ON COMPANY PROCEDURES RELATING TO THE 2021 ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL INDUSTRY

GUIDELINES ON COMPANY PROCEDURES RELATING TO THE 2021 ABPI CODE OF PRACTICE FOR THE PHARMACEUTICAL INDUSTRY

Press release: 07 July 2021
New PMCPA Manager - Mr Keval Dabba

New PMCPA Manager - Mr Keval Dabba

Press release: 07 July 2021
2021 Interactive ABPI Code of Practice - Comes into operation 1 July 2021

2021 Interactive ABPI Code of Practice - Comes into operation 1 July 2021

Press release: 28 June 2021
Consultation on Amendments to the mandatory template for the 2021 ABPI Code

Consultation on Amendments to the mandatory template for the 2021 ABPI Code

Press release: 08 June 2021
28 May 10:00 – 12:00: PMCPA webinar on forthcoming 2021 Code of Practice – for those not able to attend the series of webinars for pharmaceutical companies

28 May 10:00 – 12:00: PMCPA webinar on forthcoming 2021 Code of Practice – for those not able to attend the series of webinars for pharmaceutical companies

Press release: 27 April 2021
Consultation on Amendments to the Agreed 2021 ABPI Code

Consultation on Amendments to the Agreed 2021 ABPI Code

Press release: 24 March 2021
Camurus, Accord, Swedish Orphan Biovitrum (Sobi), Strides Pharma, Boehringer Ingelheim, Vifor Pharma, GlaxoSmithKline and Sintetica named in advertisements for breaches of the ABPI Code

Camurus, Accord, Swedish Orphan Biovitrum (Sobi), Strides Pharma, Boehringer Ingelheim, Vifor Pharma, GlaxoSmithKline and Sintetica named in advertisements for breaches of the ABPI Code

Press release: 02 March 2021
About 186 result(s)